SI
Scinai Immunotherapeutics Ltd
🇺🇸XNAS.SCNIUnited StatesHealthcare
$0.46USDdown -0.03 (-6.12%)OpenEnd of day5:14 PM
Price$0.46-0.03 (-6.12%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US09073Q3039
- CUSIP
- Not reported
Company
- Employees
- 45
- Headquarters
- Jerusalem, United States
- Website
- https://www.scinai.com
- CEO
- Mr. Amir Reichman M.B.A., M.Sc.
Market
- Shares outstanding
- 677.6K
- Market cap
- $1.82M
Highlights
- Market cap
- $1.82M
- EPS LTM
- -$11.72calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.04calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.45M+220.24%up year on year
- Net income
- -$7.94M-319.43%down year on year
- Gross margin
- -87.39%+39.75%up year on year
- Free cash flow
- -$5.4M+19.77%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.